RAD51AP1 and acute myeloid leukemia: Overexpression of RAD51AP1 has been described in other cancers, notably cholangiocarcinoma [17], hepatocellular carcinomas [7] and acute myeloid leukemia with complex karyotypic abnormalities [18].